Hasse Herlevsen (Cobo Technologies ApS)

Herlevsen, Hasse (Cobo Technologies 201904– COO + Co-Owner before Leo Pharma)

	Organisation	Cobo Technologies ApS
	Group	Cobo Technologies (Group)
	Former/major organisation	Leo Pharma A/S
	Group	Leo Pharma (Group)
	Product	genome editing quality control
	Product 2	quality control diagnostics

Cobo Technologies ApS. (4/23/19). "News: Welcome to Our New COO, Hasse Herlevsen".

To further strengthen our expertise within the Quality Control field, Hasse Herlevsen (former Corp. VP Quality, LEO Pharma) will join our team as COO.

Hasse will be responsible for the daily operation including all internal/external QC related projects. In addition he will also lead our membership in the NIST - Genome Editing Consortium and advise customers about standards and guidelines within the CRISPR Medicine field.

Record changed: 2019-07-06

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for Hasse Herlevsen

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]